Victor Weigman, Ph.D. | April 05, 2018

Review of Immunotherapy Landscape and Importance of Biomarkers

Critical next steps to optimize your clinical trial design
Immunotherapies provide huge potential to fight against cancer. This presentation provides an overview of the immunotherapy landscape and growth of trials, lessons learned from past trials, as well as selecting the appropriate biomarker strategy to optimize trial design.

Victor Weigman, Ph.D., Director Translational Genomics

Related Services: